Lupin Limited, global pharmaceutical company, announced the launch of the United States Food and Drug Administration (FDA) approved meloxicam capsules, 5 mg, and 10 mg.Meloxicam capsules, 5 mg and 10 mg, is the generic equivalent of Vivlodex capsules, 5 mg and 10 mg, of Zyla Life Sciences US, Inc., and indicated for management of osteoarthritis (OA) pain.Meloxicam capsules had an annual sales of approximately US$ 11 million in the US, according to IQVIA MAT October 2020.
